PCYO vs DHR vs TMO vs MSEX

For growth investors, Thermo Fisher Scientific Inc.

(TMO) is the stronger pick with 3. 9% revenue growth year-over-year, versus -9. 3% for Pure Cycle Corporation (PCYO). Pure Cycle Corporation (PCYO) offers the better valuation at 21. 6x trailing P/E, making it the more compelling value choice. Analysts rate Pure Cycle Corporation (PCYO) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Pure Cycle Corporation (PCYO) is the cheapest at 21.

6x versus Danaher Corporation at 34. 9x. On forward P/E, Thermo Fisher Scientific Inc. is actually cheaper at 19. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Thermo Fisher Scientific Inc. wins at 9. 05x versus Danaher Corporation's 34. 35x.

Over the past 5 years, Thermo Fisher Scientific Inc.

(TMO) delivered a total return of +2. 8%, compared to -28. 4% for Middlesex Water Company (MSEX). Over 10 years, the gap is even starker: TMO returned +229. 1% versus MSEX's +62. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Middlesex Water Company (MSEX) is the lower-risk stock at -0.

12β versus Thermo Fisher Scientific Inc. 's 1. 10β — meaning TMO is approximately -983% more volatile than MSEX relative to the S&P 500. On balance sheet safety, Pure Cycle Corporation (PCYO) carries a lower debt/equity ratio of 5% versus 85% for Middlesex Water Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Thermo Fisher Scientific Inc.

(TMO) is pulling ahead at 3. 9% versus -9. 3% for Pure Cycle Corporation (PCYO). On earnings-per-share growth, the picture is similar: Pure Cycle Corporation grew EPS 12. 5% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, MSEX leads at 6. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Pure Cycle Corporation (PCYO) is the more profitable company, earning 50.

3% net margin versus 14. 7% for Danaher Corporation — meaning it keeps 50. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PCYO leads at 29. 4% versus 18. 2% for TMO. At the gross margin level — before operating expenses — PCYO leads at 61. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Thermo Fisher Scientific Inc. (TMO) is the more undervalued stock at a PEG of 9. 05x versus Danaher Corporation's 34. 35x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Thermo Fisher Scientific Inc. (TMO) trades at 19. 1x forward P/E versus 20. 8x for Danaher Corporation — 1. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 40. 6% to $247. 00.

In this comparison, MSEX (2.

7% yield), DHR (0. 7% yield), TMO (0. 4% yield) pay a dividend. PCYO does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Middlesex Water Company (MSEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

12), 2. 7% yield). Both have compounded well over 10 years (MSEX: +62. 9%, TMO: +229. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PCYO (Utilities) and DHR (Healthcare) and TMO (Healthcare) and MSEX (Utilities)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

DHR, MSEX pay a dividend while PCYO, TMO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.